slide deck (pdf) - CME Outfitters
slide deck (pdf) - CME Outfitters slide deck (pdf) - CME Outfitters
Common Contraindications of Antimuscarinics ! Urinary or gastric retention ! Uncontrolled narrow-angle glaucoma ! Clinically significant bladder outlet obstruction Physicians’ Desk Reference. 64st ed. Montvale, NJ: Thomson PDR; 2010. Oelke M, et al. Eur Urol. 2013;64(1):118-140. PMID: 23541338.
Beta 3 Agonists Drug Mirabegron Dosing 25 – 50 mg per day Common side effects: hypertension, nasopharyngitis, urinary tract infections and headache. Caution should be used in patients with clinically significant bladder outlet obstruction. PI for mirabegron. Drugs@FDA Website. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf. 2013. Rosenberg MT, et al. Publication pending.
- Page 9 and 10: Disclosures ! Faculty of this CE ac
- Page 11 and 12: Get Social with Us CMEOutfitters.co
- Page 13 and 14: Georgia Association of Physician As
- Page 15 and 16: Matt T. Rosenberg, MD Disclosures S
- Page 17 and 18: In what percentage of your patients
- Page 19 and 20: Function of the Prostate Normal Fun
- Page 21 and 22: Benign Prostatic Hyperplasia ! A co
- Page 23 and 24: Predominant Symptoms ! The enlarged
- Page 25 and 26: Definition of OAB International Con
- Page 27 and 28: How to differentiate the etiology o
- Page 29 and 30: Common Comorbidities in BPH-LUTS Co
- Page 31 and 32: Audience Response Question Fact: ED
- Page 33 and 34: BPH-LUTS and ED Common Pathophysiol
- Page 35 and 36: What to Keep in Mind in the Evaluat
- Page 37 and 38: The Evaluation of LUTS: History, Ph
- Page 39 and 40: Medications Can Cause or Exacerbate
- Page 41 and 42: Laboratory Tests ! Urinalysis ! Inf
- Page 43 and 44: Audience Response Question The most
- Page 45 and 46: The Purpose of the Voiding Diary !
- Page 47 and 48: Rosenberg MT, et al. Publication Pe
- Page 49 and 50: STEP 1: Informed Surveillance If th
- Page 51 and 52: Clinical Management Step2a: Alpha B
- Page 53 and 54: Clinical Management Step2b: Phospho
- Page 55 and 56: Rosenberg MT, et al. Publication Pe
- Page 57 and 58: Antimuscarinics - Immediate Release
- Page 59: ! Dry Mouth ! Constipation ! Headac
- Page 63 and 64: Clinical Management Step3b: Adding
- Page 65 and 66: 5 Alpha Reductase Inhibitors (5ARI)
- Page 67 and 68: Rosenberg MT, et al. Publication Pe
- Page 69 and 70: Clinical Connections: Summary ! Tre
Common Contraindications of<br />
Antimuscarinics<br />
! Urinary or gastric retention<br />
! Uncontrolled narrow-angle glaucoma<br />
! Clinically significant bladder outlet<br />
obstruction<br />
Physicians’ Desk Reference. 64st ed. Montvale, NJ: Thomson PDR; 2010.<br />
Oelke M, et al. Eur Urol. 2013;64(1):118-140. PMID: 23541338.
Change language